aSchizophrenia Program, Centre for Addiction and Mental Health
bDivision of Neurology and Toronto Western Research Institute, University of Toronto, Toronto, Ontario, Canada
cDepartment of Psychiatry, Ernst Moritz Arndt University of Greifswald, Mecklenburg-Vorpommern, Germany
dDepartment of Psychiatry, University of California, San Diego, California
eDepartment of Psychiatry, VA Boston Healthcare System/Harvard Medical School, Boston, Massachusetts, USA
fPsychiatry Research Centre, The Alfred and Monash University Department of Psychological Medicine, Victoria, Australia
Correspondence to Zafiris Jeff Daskalakis, MD, PhD, FRCP(C), Staff Psychiatrist, Schizophrenia Program, Associate Professor of Psychiatry, Centre for Addiction and Mental Health, University of Toronto, 250 College Street, 7th Floor, M5T 1R8, Toronto, Ontario, Canada
Tel: +416 535 8501, ext: 4319; fax: +416 979 6936; e-mail: [email protected]
Received 8 May 2007; accepted 15 June 2007